Inhibiting the production of Hcy-thiolactone (HTL), which is facilitated by MARS, thereby reducing K-Hcy changes, has been shown to decrease DNA damage and CRC cell proliferation. The gene discussed is MARS1; the disease is colorectal carcinoma.